Skip Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
Special Pathogens
Secondary Navigation
NCID Home Contact Us
Site Contents
Mission Statement
Disease / Virus Information

Education and Prevention Materials
 
 HPS Materials
 Infection Control for VHFs in the African Health Care Setting
 Laboratory Management: Biosafety Guidelines
 Lassa Fever Online Slideset
 "Lassa" Online Video
 Methods for Trapping and Sampling Small Mammals
 Print and Video Materials Available by Mail
 Other Resources
 Research Publications
 Specimen Submission Information
 Outbreak Postings
 Glossary
"Infection Control for Viral Haemorrhagic Fevers
In the African Health Care Setting"


Annexes 1-5


Annex 1 Standard Precautions for Hospital Infection Control13 Go to top of page

Standard Precautions aim to reduce the risk of disease transmission in the health care setting, even when the source of infection is not known. Standard Precautions are designed for use with all patients who present in the health care setting and apply to:

  • Blood and most body fluids whether or not they contain blood

  • Broken skin

  • Mucous membranes.


To reduce the risk of disease transmission in the health care setting, use the following Standard Precautions.

  1. Wash hands immediately with soap and water before and after examining patients and after any contact with blood, body fluids and contaminated item--whether or not gloves were worn. Soaps containing an antimicrobial agent are recommended.

  2. Wear clean, ordinary thin gloves anytime there is contact with blood, body fluids, mucous membrane, and broken skin. Change gloves between tasks or procedures on the same patient. Before going to another patient, remove gloves promptly and wash hands immediately, and then put on new gloves.

  3. Wear a mask, protective eyewear and gown during any patient-care activity when splashes or sprays of body fluids are likely. Remove the soiled gown as soon as possible and wash hands.

  4. Handle needles and other sharp instruments safely. Do not recap needles. Make sure contaminated equipment is not reused with another patient until it has been cleaned, disinfected, and sterilized properly. Dispose of non-reusable needles, syringes, and other sharp patient-care instruments in puncture-resistant containers.

  5. Routinely clean and disinfect frequently touched surfaces including beds, bed rails, patient examination tables and bedside tables.

  6. Clean and disinfect soiled linens and launder them safely. Avoid direct contact with items soiled with blood and body fluids.

  7. Place a patient whose blood or body fluids are likely to contaminate surfaces or other patients in an isolation room or area.

  8. Minimize the use of invasive procedures to avoid the potential for injury and accidental exposure. Use oral rather than injectable medications whenever possible.

When a specific diagnosis is made, find out how the disease is transmitted. Use precautions according to the transmission risk.

  • If airborne transmission:

    1. Place the patient in an isolation room that is not air-conditioned or where air is not circulated to the rest of the health facility. Make sure the room has a door that can be closed.

    2. Wear a HEPA or other biosafety mask when working with the patient and in the patient's room.

    3. Limit movement of the patient from the room to other areas. Place a surgical mask on the patient who must be moved.

 

  • If droplet transmission:

      1. Place the patient in an isolation room.

      2. Wear a HEPA or other biosafety mask when working with the patient.

      3. Limit movement of the patient from the room to other areas. If patient must be moved, place a surgical mask on the patient.

  • If contact transmission:

      1. Place the patient in an isolation room and limit access.

      2. Wear gloves during contact with patient and with infectious body fluids or contaminated items. Reinforce handwashing throughout the health facility.

      3. Wear two layers of protective clothing.

      4. Limit movement of the patient from the isolation room to other areas.

      5. Avoid sharing equipment between patients. Designate equipment for each patient, if supplies allow. If sharing equipment is unavoidable, clean and disinfect it before use with the next patient.

       

13 Adapted from Garner JS, Hospital Infection Control Practices Advisory Committee. Guideline for Isolation Precautions In Hospitals, January 1996. Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta,Georgia.


Annex 2 Specific Features of VHFs14 Go to top of page

Geographical and epidemiological characteristics of VHFs

Disease Geography Vector/ Reservoir Human Infection
Crimean Congo HF -Africa -Balkans
-China (Western)
-Former Soviet
Union (Southern)
-Middle East
Ticks. Tick mammal-tick maintenance.

--Tick bites.
--Squashing ticks.
-- Exposure to aerosols or fomites from slaughtered cattle and sheep (domestic animals do not show evidence of illness but may become infected when transported to market or when held in pens for slaughter).
--Nosocomial epidemics have occurred.

Dengue HF, Dengue Shock Syndrome (DHF/DSS) All Tropic and subtropical Regions Aedes aegypti mosquitoes. Mosquito-human mosquito maintenance. Transmission occurs with the frequent geographic transport of viruses by travelers. Increased worldwide distribution of the mosquito and the movement of dengue viruses in travelers is increasing the areas that are becoming infected.
Ebola HF and Marburg HF Africa Unknown.

--Virus is spread by close contact with an infected person.
--Route of infection of the first case is unknown.
--Infected non human primates sometimes provide transmission link to humans.
--Aerosol transmission is suspected in some monkey infections.

Lassa Fever West Africa Mice. The Mastomys genus of the mouse.

--Transmitted by aerosols from rodent to man.
-- Direct contact with infected rodents or their droppings, urine, or saliva.
--Person - to person contact.
Note: The reservoir rodent is very common in Africa and the disease is a major cause of severe febrile illness in West Africa

Rift Valley Fever Sub-Saharan Africa Floodwater mosquitoes.
Maintained between mosquitoes
and domestic animals, particularly
sheep and cattle.

--Mosquito bite.
--Contact with blood of infected sheep, cattle, or goats.
--Aerosols generated from infected domestic animal blood.
--No person -to person transmission observed.

Yellow Fever --Africa
--South America
Aedes aegypti mosquitoes.
Mosquito - monkey - mosquito maintenance. Occasional human
infection occurs when unvaccinated humans enter forest. In an urban outbreak, virus maintained in infected Aedes aegypti mosquitoes and humans.

--Mosquito bite.
-- In epidemics, mosquitoes amplify transmission between humans.
--Fully developed cases cease to be viremic. Direct person-to person transmission is not believed to be a problem although the virus is highly infectious (including aerosols) in the laboratory.


14 Peters CJ, Zaki SR, Rollin PE. Viral Hemorrhagic Fevers, Chapter 10 in Atlas of Infectious Diseases, vol 8, vol ed Robert Fekety, book ed GL Mandell. Philadelphia: Churchill Livingstone. 1997: pp10.1-10.26.

Common Clinical Features of VHFs

Disease Incubation Period Case Fatality Characteristic Features
Crimean Congo HF 3-12 days 15%-30%

Most severe bleeding and ecchymoses (a purplish patch caused by blood coming from a vessel into the skin) of all the HF.

Ebola HF and Marburg HF 2-21 days 25%-90%

--Most fatal of all HF.
-- Weight loss.
--Exhaustion and loss of strength.
--A maculopapular (a lesion with a broad base) rash is common
--Post infection events have included hepatitis, uveitis and orchitis.

Lassa Fever 5-16 days

Approximately
15%

--Exhaustion and loss of strength.
--Shock.
--Deafness develops during recovery in 20% of cases.
Rift Valley Fever 2-5 days (uncomplicated disease; incubation for HF may differ) 50% of severe cases (about 1.5% of all infections)

--Shock.
-- Bleeding.
--Reduced or no urine production.
--Jaundice.
--Inflammation of the brain.
--Inflammation of the blood vessels in the retina of the eye.

Yellow Fever 3-6 days 20% -- Acute febrile period followed by a brief period of remission.
--Toxic phase follows remission with jaundice and renal failure in severe cases.

Specific Clinical Findings in Different VHFs

Disease Crimean Congo HF Ebola HF and Marburg HF Lassa Fever Rift Valley Fever Yellow Fever
haemorrhage +++ ++ + ranging to S +++ +++
thrombo-cytopenia 1 +++ +++ +

+++

++
leukocyte
count 2
down arrowdown arrow ranging to up arrow data not available no change data not available no change ranging to down arrowdown arrow
rash
+++ ++

icterus3 ++ ++
++ +++
renal disease


+ ++
pulmonary disease + + + data not available +
tremor4
dysarthria5


+
 
encephalo-pathy6 + ++ + ranging to S E ++
deafness
+ ++
 
eye lesions
Retinitis
Retinitis

 

1 abnormally low number of platelets in the circulating blood + occasional or mild
2 white blood cell count ++ commonly seen and may be severe
3 jaundice +++ characteristic
4 shaking S characteristic and seen in severe cases
5 difficulty speaking and pronouncing words due to problems with the muscles used for speaking up arrow occasionally or mildly increased
down arrowdown arrow commonly decreased
6 disease of the brain E May develop true encephalitis

 

A Summary of Prevention and Treatments of VHFs

Disease Prevention Treatment
Crimean Congo HF --Tick avoidance.
--Avoid contact with acutely infected animals, especially slaughtering.
--Use VHF Isolation Precautions when a case is suspected.

--Ribavirin is effective in reducing mortality.
--Ribavirin should be used based on in vitro sensitivity and of limited South African experience.

Dengue HF, Dengue Shock Syndrome (DHF/DSS) --Mosquito control of Aedes aegypti.
--Vaccines currently under investigation for probable use in travellers but unlikely to be a solution to hyperendemic dengue transmission that leads to dengue HF.
--Supportive care. It is effective and greatly reduces mortality.
Ebola HF and Marburg HF --Standard Precautions including needle sterilization in African hospitals are particularly important.
--Use VHF Isolation Precautions when a case is suspected.
--Avoid unprotected contact with suspected patients or infectious body fluids.
--Avoid contact with monkeys and apes.
--None other than supportive care, which may be of limited utility.
--Antiviral therapies urgently needed.
Lassa Fever --Rodent control.
--Use VHF Isolation Precautions when a case is suspected.
--Ribavirin is effective in reducing mortality.
--Use Ribavirin in higher risk patients, e.g. if aspartate aminotransferase (AST) is greater than 150.
Rift Valley Fever --Vaccination of domestic livestock prevents epidemics in livestock but not sporadic, endemic infections of humans.
--Human vaccine safe and effective, but in limited supply.
--Veterinarians and virology workers in sub-Saharan Africa are candidates for vaccine.

--Supportive care.
--Use Ribavirin in haemorrhage fever patients (based on studies in experimental animals).

Yellow Fever -- Mosquito control of Aedes aegypti would eliminate urban transmission but forest transmission remains.
--Vaccine is probably the safest and most effective in the world.
-- Supportive care.

History of Viral Haemorrhagic Fevers Seen in Your Area
Major Signs and Symptoms
Transmission Route
     
     
     
     

Annex 3 Planning and Setting Up the Isolation Area Go to top of page

Checklist: Supplies for a Changing Room

Storage Outside the Changing Room:

 

1. Shelf or cabinet with lock ____
2. Supply of clean scrub suits, gowns, aprons, gloves, masks, headcovering, and eyewear ____
3. Covered shelf for storing disinfected boots ____
4. Bucket for collecting non-infectious waste ____



Inside the Changing Room:

1. Hooks, nails, or hangers for hanging reusable gowns, scrub suits _____

2. Roll of plastic tape
_____
3. Handwashing supplies: bucket or pan, clean water, soap, one-use towels _____
4. Bucket or pan, 1:100 bleach solution for disinfecting gloved hands _____
5. Container with soapy water for collecting discarded gloves _____
6. Container with soapy water for collecting used instruments to be sterilized* _____
7. Container with soapy water for collecting reusable gowns, masks, sheets to launder* _____


*Place outside the changing room if the changing room is too small

If large amounts of waste on floor:


Sprayer, bucket or shallow pan with 1:100 bleach solution for disinfecting boots

Checklist: Supplies for Patient Area

1. 1 bed with clean mattress or sleeping mat and at least a bottom sheet and blanket for each bed _____
2. Plastic sheeting to cover mattress or sleeping mat _____
3. 1 thermometer, 1 stethoscope, and 1 blood pressure cuff for each patient or for each patient area _____
4. 1 puncture-resistant container for collecting non-reusable needles, syringes, and discarded sharp instruments _____
5. 1 bedside table or shelf _____

6. 1 large wall clock with a second hand
_____
7. Pan with 1:100 bleach solution or alcohol and one-use towels for disinfecting the thermometer and stethoscope between use with each patient _____
8. Bucket or pan, 1:100 bleach solution, one-use towels for disinfecting gloved hands between patients _____
9. Supplies for disinfecting patient excreta (bedpan, urinal, 1:10 bleach solution) _____
10. Sprayer, 1:100 bleach solution, clear water, and mop for disinfecting spills on floor and walls _____
11. Container with soapy water for collecting discarded gloves _____
12. Screens (or sheets hung from ropes or lines) placed between VHF patients' beds _____
13. Extra supply of gowns and gloves _____
14. Container for collecting infectious waste to be burned _____

Use the grid on the next page to draw the layout of an isolation area in your own health facility. Be sure to include:

  • Area for patient isolation

  • Changing room for health care workers to use for changing clothes

  • Area for cleaning and laundering VHF-contaminated supplies

  • Changing area for cleaning staff who handle VHF-contaminated waste but who do not do direct patient-care activities.


Planning Grid: Layout for Isolation Area in Your Health Facility

                                       
                                       
                                       
                                       
                                       
                                       
                                       
                                       
                                       
                                       
                                       
                                       
                                       
                                       
                                       
                                       
                                       
                                       
                                       
                                       

 

Annex 4 Adapting VHF Isolation Precautions for a Large Number of Patients Go to top of page

The recommendations in this manual assume 1 or 2 VHF cases have occurred in a non-outbreak situation. When more than 1 or 2 VHF patients present in the health facility, additional precautions need to be taken. When Ebola haemorrhagic fever occurs, initially there may be as many as 10 cases.

When a VHF is suspected, develop a case definition based on the VHF that has occurred. Use it to identify new cases during the outbreak.

For example, the current case definition for suspecting Ebola haemorrhagic fever (EHF) is:

Anyone presenting with fever and signs of bleeding such as:

  • Bleeding of the gums
  • Bleeding from the nose
  • Red eyes
  • Bleeding into the skin (purple coloured patches in the skin)
  • Bloody or dark stools
  • Vomiting blood
  • Other unexplained signs of bleeding

Whether or not there is a history of contact with a suspected case of EHF.

OR

Anyone living or deceased with:

  • Contact with a suspected case of EHF AND
  • A history of fever, with or without signs of bleeding.

OR

Anyone living or deceased with a history of fever AND 3 of the following symptoms:

  • Headache
  • Vomiting
  • Loss of appetite
  • Diarrhoea
  • Weakness or severe fatigue
  • Abdominal pain
  • Generalized muscle or joint pain
  • Difficulty swallowing
  • Difficulty breathing
  • Hiccups


OR

Any unexplained death in an area with suspected cases of EHF.


The current case definition for suspecting Lassa fever is:

Unexplained fever at least 38°C or 100.4°F for one week or more.

And 1 of the following:

  • No response to standard treatment for most likely cause of fever (malaria, typhoid fever)

  • Readmitted within 3 weeks of inpatient care for an illness with fever

And 1 of the following:

  • Edema or bleeding
  • Sore throat and retrosternal pain/vomiting
  • Spontaneous abortion following fever
  • Hearing loss following fever

Prepare Your Health Facility


If there are more than 2 suspected VHF patients, take steps immediately to adapt the VHF Isolation Precautions for a large number of patients.

  1. Reinforce the use of Standard Precautions --especially handwashing-- throughout the health facility. Make sure there is a reliable supply of soap and clean water in areas where health facility staff have contact with patients suspected as having a VHF.

  2. Make sure adequate supplies of protective clothing are available.

  3. Set up a temporary area that is separate from the rest of the facility where febrile patients can wait to be seen by a health care worker. Also use this area for patients who have been seen by a health care worker and who are waiting to go to the isolation area.

    Make sure the temporary admission area contains a supply of protective clothing, buckets with disinfectants in them for collecting disposable waste, and disinfectants for cleaning and disinfecting spills of infectious materials.

  4. Identify a family liaison person from the health facility staff who can spend time with families to answer questions, provide information about the VHF and its transmission. If family members help provide care when relatives are in hospital, make sure they know how to use protective clothing when they are with the patient in the isolation area. Help families with arrangements for cooking, washing and sleeping.

  5. Designate a separate building or ward for placing patients with the same disease together in a single isolation area. Select and isolate a toilet or latrine for disposal of disinfected patient waste and other liquid waste.

  6. Restrict access to the building or ward set aside as the isolation area. Set up walkways from the temporary area to the isolation area by tying ropes along the walkway and hanging plastic sheets from them.

  7. Prepare a list of health facility staff authorized to enter the isolation area. Station a guard at the entry to the isolation area, and provide the guard with the list of authorized persons. The guard will use the list to limit access to the isolation area to authorized health facility staff and, if necessary, the caregiving family member.

  8. Provide the guard with a sign-in sheet for recording who goes into the isolation area and the time of entry and departure.

  9. Prepare a large quantity of disinfectant solutions each day (bleach solutions and detergent solutions). Store the disinfectants in large containers. Ask cleaning staff to change the disinfectants when they become bloody or cloudy or when the chlorine odour is no longer detectable.

  10. Obtain additional patient supplies. Make sure each patient has a bed and mattress or sleeping mat. Designate medical equipment for use with each VHF patient (for example, a thermometer, a stethoscope, and a blood-pressure cuff for each patient). If there are not enough items available to provide one per patient, be sure to clean and disinfect the items before use with the next patient.

  11. Make sure schedules are carried out as planned for collecting, transporting and burning infectious waste daily. Make sure that burning is supervised and that security of the burning site is maintained.

  12. Initiate community education activities.


Annex 5 Making Protective Clothing Go to top of page
 
A homemade headcover
A homemade
headcover

Instruction on Making Headwear

Materials needed:

Elastic 3/4 meter

Cotton cloth 51 cm2 (20 square inches)

 

 

Cut a round piece of cloth

1. Cut a round piece of cotton cloth that is 46 to 50 cm (18 to 20 inches) in diameter.

 

 

 

 

Sew elastic

2. Sew elastic on the edge and shape a circle 18 cm (7 inches) in diameter.

 



Instruction on Making Gown

Materials needed:

1.5 meters cotton cloth to make one gown

 

Directions for making a gown

 

Instruction on Making Aprons


Materials needed (to make 2 aprons):

1 1/4 meters plastic sheeting or plastic cloth used for covering tables

91 cm (36 inches) sewing tape

 

apron

 

Instruction on Making a Cotton Mask


1 meter cotton cloth to make at least 2 masks

50 cm in second colour to make the inside of the masks

Cut 4 pieces of cotton cloth - 20x28-30cm

1. Cut 4 pieces of cotton cloth to the size shown.

 

 

Sew pieces with vertical length at 13 cm

2. Cut 1 piece from a different colour. Use it as the inside of the mask.

 

Sew ties on mask

3. Sew the 5 pieces together and gather or pleat the vertical sides to 13 cm (5 inches) long. Sew all pieces in place. 28 to 30 cm (11 to 12 inches) 20 cm (8 inches) 13 cm (5 inches)

4. Sew on ties.

 

Infection Control For VHFs Manual
 Return to Main Table of Contents
Sections on this page
 Annex 1 Standard Precautions for Hospital Infection Control
 Annex 2 Specific Features of VHFs
 Annex 3 Planning and Setting Up the Isolation Area
 Annex 4 Adapting VHF Isolation Precautions for a Large Number of Patients
 Annex 5 Making Protective Clothing
Download and print the PDF of this section
English Version
Acrobat annex 1
Acrobat annex 2
Acrobat annex 3
Acrobat annex 4
Acrobat annex 5
French Version
Acrobat annexe 1
Acrobat annexe 2
Acrobat annexe 3
Acrobat annexe 4
Acrobat annexe 5
Download Entire
Manual
Acrobat English
Acrobat French

 Acrobat Some documents are available here in Adobe Acrobat Reader format (PDF). To view or print them, you must have Adobe Acrobat Reader (version 3.0 or higher) installed on your computer. If you do not have the reader, you can obtain it free from Adobe Corporation. Click on the icon below to download the program from their Web site.
Get Adobe Acrobat Reader

  Top of Page

 

Special Pathogens Home | | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed November 26, 2003

National Center for Infectious Diseases
Centers for Disease Control and Prevention

Privacy Policy | Accessibility